Hydra Biosciences, Inc Company Profile

03:08 EDT 17th October 2018 | BioPortfolio

Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels. Tapping the unharnessed power of the body to heal itself is one of the last frontiers of medicine. With the identification of many animal genomes, it is now possible to identify the genes and pathways that can unleash the regenerative power locked within the human body.


790 Memorial Drive
United States of America


Phone: (617) 494 - 5230
Fax: (617) 494 - 5245

News Articles [662 Associated News Articles listed on BioPortfolio]

Daré Bioscience, Inc. Announces Asset Transfer Agreement with Hydra Biosciences, Inc. for CatSper Contraceptive Target

CatSper antagonist has potential to provide pregnancy prevention via administration to either women or men as a novel, rapidly reversible, non-hormonal contraceptive SAN DIEGO, July 16, 2018 (G...

Guerbet launches L─F Hydra Vision Digital Imaging System for urological imaging

Guerbet LLC USA, part of Guerbet Group, the global specialist in contrast product and solutions for medical imaging, announced the launch of the L─F Hydra Vision Digital Imaging System, a new real...

Guerbet launches L-F Hydra Vision digital urological imaging system

Guerbet LLC USA, part of Guerbet Group, has launched the L-F Hydra Vision digital imaging system, a new real-time digital X-ray imaging device developed to streamline workflow and improve efficiency i...

An AI for Deciphering What Animals Do All Day

Spam-filtering algorithm learns to recognize full set of behaviors in jelly-like Hydra

Strategic partnership forms between Taconic Biosciences and Cyagen Biosciences

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services.

Image of the Day: Spammed by Hydra

A junk mail filter can learn to pick out six behaviors of hydras by analyzing hours of video footage.

SOLID BIOSCIENCES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Solid Biosciences Inc. to Contact The Firm

NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Solid Biosciences Inc. ("Solid Biosciences" or th...

African Women for Biosciences Platform Launched

Women in biosciences remain grossly under represented in leadership and decision-making levels, limiting contribution of scientific research to national development. A new platform - the African Women...

PubMed Articles [66 Associated PubMed Articles listed on BioPortfolio]

Analysis of the conserved NER helicases (XPB and XPD) and UV-induced. DNA damage in Hydra.

Nucleotide excision repair (NER) pathway is an evolutionarily conserved mechanism of genome maintenance. It detects and repairs distortions in DNA double helix. Xeroderma Pigmentosum group B (XPB) and...

Ecotoxicity responses of the freshwater cnidarian Hydra attenuata to 11 rare earth elements.

Lanthanides are the major family of rare earth elements (REEs) owing to the essential properties these metallic species provide in diverse fields of today's world economy. They are now being mined and...

Hydra's feeding response: Effect of GABA ligands on GSH-induced electrical activity in the hypostome of H. vulgaris.

The feeding response in the Cnidarian, hydra, consists of mouth opening, tentacle writhing, and the cessation of pacemaker-controlled tentacle and body contractions. The behavior can be induced by red...

The hydra of anesthetic neurotoxicity: Myth or reality?

NR3E receptors in cnidarians: A new family of steroid receptor relatives extends the possible mechanisms for ligand binding.

Steroid hormone receptors are important regulators of development and physiology in bilaterian animals, but the role of steroid signaling in cnidarians has been contentious. Cnidarians produce steroid...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

The purpose of this study is the evaluation of the performance, safety and efficacy of Hydra Aortic valve in real-world patients. Following initial implantation, all patients will have cli...

Tangible Hydra-PEG: A Promising Solution for Scleral Lens Wearers With Dry Eye

Tangible Hydra-PEG is a novel coating technology designed to improve lens wettability, deposit resistance, and tear film breakup time. This is a randomized double masked cross-over study t...

Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)

The purpose of the study is to analyze the sensation to eye drops containing menthol in people with healthy eyes and in people with dry eyes. This study also examines the temperature of yo...

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Companies [366 Associated Companies listed on BioPortfolio]

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Hydra Biosciences, Inc

Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels. Tapping the unharnessed power of th...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Hydra Biosciences, Inc" on BioPortfolio

We have published hundreds of Hydra Biosciences, Inc news stories on BioPortfolio along with dozens of Hydra Biosciences, Inc Clinical Trials and PubMed Articles about Hydra Biosciences, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Hydra Biosciences, Inc Companies in our database. You can also find out about relevant Hydra Biosciences, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Corporate Database Quicklinks

Searches Linking to this Company Record